Relief in South Africa after J&J reversal allows key tuberculosis drug production at lower prices
CAPE TOWN, South Africa — Medical advocacy groups have welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices, after South African authorities opened an investigation into the conglomerate. The South African Competition Commission in a statement on July 5 said it decided … Read more
